These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6765149

  • 1. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
    Michaelis D, Rjasanowski I, Ratzmann KP, Strese J, Dietz H, Hildmann W.
    Acta Biol Med Ger; 1982; 41(12):1093-8. PubMed ID: 6765149
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of islet cell antibody and islet cell surface antibody in diabetics].
    Iwo K.
    Nihon Rinsho; 1990 Dec; 48 Suppl():300-7. PubMed ID: 2086903
    [No Abstract] [Full Text] [Related]

  • 5. A population survey of pancreatic islet cell antibodies.
    Rodger B, Whittingham S, Martin FI, Hawkins BR, Dawkins RL, Welborn TA.
    Clin Exp Immunol; 1980 Jan; 39(1):125-9. PubMed ID: 6993063
    [Abstract] [Full Text] [Related]

  • 6. [HLA and type-1 diabetes: a prospective study of all new cases diagnosed in Piedmont in one year].
    Amoroso A, Borelli I, De Marchi M, Savi M, Pagano G, Cavalot F, Curtoni ES.
    Pathologica; 1983 Jan; 75 Suppl():40-50. PubMed ID: 6393018
    [No Abstract] [Full Text] [Related]

  • 7. Islet cell antibodies and diabetes in Nigerians.
    Oli JM, Bottazzo GF, Doniach D.
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Detection of human circulating islet cell surface antibodies by dispersed rat pancreatic islet cells (III). Examination of clinical significance].
    Maruyama S, Sugiura M, Tomiyama H, Aizawa T, Ishido T, Kinjyo T, Kuwae M, Mimura G.
    Rinsho Byori; 1984 Mar; 32(3):291-8. PubMed ID: 6376874
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J, Czech A, Podgórski G.
    Pol Tyg Lek; 1984 Aug 20; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
    Dorchy H, Lemiere B, Toussaint D, Gausset P.
    Nouv Presse Med; 1981 Sep 26; 10(34):2795-8. PubMed ID: 7031599
    [Abstract] [Full Text] [Related]

  • 16. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 26; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.